Nucleai

Nucleai is a Tel Aviv-based company that uses artificial intelligence to design and create solutions for the healthcare industry, specifically for cancer diagnostics. It has the stated goal to improve cancer diagnostics making it accurate, effective, accessible and efficient in order to treat patients better by using machine learning, deep learning, and machine vision technology.

The company's products are cloud-based and can be used to extract unique information from biopsies to better match the right patient to the right treatment and aid the pathologist in their findings. They can be used for colon, stomach, breast, and prostate biopsies. One of its products is pathology automation, which consists of the structuring and qualification of tissue images. Its other product is treatment prediction, which utilizes biomarkers and artificial intelligence to anticipate the optimal treatment for a cancer patient.The products also use data that has been extracted from Israeli hospitals in order to make predictions.